Anat Ashkenazi

Anat Ashkenazi

Executive Vice President and Chief Financial OfficeratEli Lilly & Co· In proxies 2021–2024

Pay in FY2024-35% from the year before

Anat Ashkenazi was paid $5.0M in FY2024 (Dec), down 35%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Eli Lilly & Co proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Eli Lilly & CoPublic company · 5 yr
    • Executive Vice President and Chief Financial Officer2021 – Present · 5 yrNo stock prices for these years
  2. Maravai Lifesciences HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Varian Medical Systems, Inc.Public company · 3 yr
    • Director2018 – 2021 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?